Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hair
Biotech
Inside Absci's quest to become the Apple of biotech
By targeting large unmet markets in hair loss and endometriosis with a direct-to-consumer approach, Absci is on a mission to become a household name.
Darren Incorvaia
Sep 2, 2026 3:00am
Fierce Pharma
Veradermics locks in $256M IPO, shares spike
Feb 5, 2026 10:01am
Fierce Pharma
Veradermics grows hair loss med hopes on $150M funding wave
Oct 16, 2025 7:30am
Pelage locks in $120M series B for hair growth program
Oct 15, 2025 7:00am
Do hairy moles hold the key to treating hair loss?
Jun 22, 2023 5:01am
AbbVie, Ipsen exit R&D deals to cap off lousy year for Exicure
Dec 14, 2022 7:15am